Clinical Trials in Denver

Showing 14421-14440 of 18,161 trials

An Observational Study of OZURDEX® in Diabetic Macular Edema (DME)

NCT02188173

This is a study of OZURDEX® use in clinical practice in patients with diabetic macular edema (DME).

Allergan200 participantsStarted Jul 2014

Phoenix, Arizona, United States • San Francisco, California, United States • Santa Ana, California, United States +15 more locations

COMPLETEDPhase 3< 1 mile

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

NCT01103284

This study will look at the treatment effect of DiaPep277 on preservation of beta-cell function, as defined by meal-stimulated secretion of insulin. DiaPep277 is a peptide that changes the way the immune system behaves, stopping its attack on the beta-cells. Adults (\>20 years) with newly diagnosed (\<6 months) type 1 diabetes will be treated with 10 injections of DiaPep277 or Placebo over a 2-year treatment and follow-up period.

Type 1 Diabetes Mellitus

Andromeda Biotech Ltd.475 participantsStarted Apr 2010

Los Gatos, California, United States • Modesto, California, United States • San Diego, California, United States +72 more locations

An Observational Study of OZURDEX® in Diabetic Macular Edema (DME)

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

Find Trials by Condition in Denver

Comparison of TAK-875 to Placebo as an Add-on to Glimepiride in Patients With Type 2 Diabetes

Study of Intravitreal Aflibercept Injection (IAI; EYLEA®; BAY86-5321) in Patients With Diabetic Macular Edema

Vistakon Investigational Contact Lenses Worn for Daily Wear

Dose Ranging Study of Celivarone With Amiodarone as Calibrator for the Prevention of Implantable Cardioverter Defibrillator (ICD) Interventions or Death

Comparison of Fasiglifam (TAK-875) to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes

TAK-875 (Fasiglifam) in Combination With Sitagliptin in Adults With Type 2 Diabetes

RSV F Dose-Ranging Study in Women

Risedronate to Prevent Skeletal Related Events in Patients With Metastatic Prostate Cancer Commencing Hormonal Therapy

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

A Study to Evaluate the Efficacy and Safety of Ibrutinib, in Patients With Mantle Cell Lymphoma Who Progress After Bortezomib Therapy

A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis

Randomized Trial of Fulvestrant With or Without Dasatinib in Men and Postmenopausal Women Who Have Hormone Receptor-positive Advanced Breast Cancer Previously Treated With an Aromatase Inhibitor

A Study to Identify and Characterize LAL-D Patients in High-risk Populations

Phase III Study of Florbetaben (BAY94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid Compared to Histopathology

A Phase 2 Study of Atacicept in Subjects With Relapsing Multiple Sclerosis (ATAMS)

An Eight-week Study of Saredutant and Escitalopram as Combination Treatment for Major Depressive Disorder

Efficacy an Safety of Volinanserin on Sleep Maintenance Insomnia With a Sub-study on Stable Type II Diabetes Mellitus

Predicting Complications in Women With Toxaemia